How many ways can drug companies resist the multi-mode drug purchase?

[market analysis of chinapharma.com] to some extent, GPO is a way for the government to transfer part of its functions to a third-party platform, no matter in Shanghai mode, Shenzhen mode, Guangzhou or Foshan mode However, after the government retired, how to supervise both drug companies and purchasers at the regulatory level will become a problem that has to be faced (how many ways can drug companies resist the multi-mode drug purchase? After Shanghai and Shenzhen, recently, Guangzhou and Hubei have also implemented the GPO model The scope of GPO implementation will be further expanded Guangzhou GPO can't go out of the provincial platform? On July 14, Guangzhou released the implementation plan for comprehensive reform of public hospitals, which clearly relied on Guangzhou public resource trading center to establish GPO platform, implement centralized procurement with volume, public hospitals to organize groups, centralized bidding procurement, and implement unified distribution However, it is intriguing that on July 19, Huang Fei, deputy director of Guangdong health and Family Planning Commission and director of Guangdong Medical Reform Office, pointed out that "provincial and municipal co construction GPO" conforms to the spirit of relevant documents such as the national No.7 document and the new medical reform work plan, and hoped that the provincial drug delivery center would consolidate the successful experience and further strengthen the platform service and supervision function He also pointed out that in order to avoid repeated construction and waste of administrative resources, Guangzhou and Foshan were used as pilot sites to explore the establishment of "GPO special area" or "urban sub center" on the provincial platform This also seems to mean that the three platforms proposed by Guangdong to promote the orderly competition of the provincial third-party drug electronic trading platform and the GPO trading platform of Guangzhou and Shenzhen are likely to face new changes It is worth noting that on July 18, the general office of the people's Government of Hubei Province issued the implementation opinions on further reforming and improving the drug procurement and supply guarantee mechanism of public hospitals (hereinafter referred to as the opinions), which clearly adopted various forms of volume procurement According to the opinions, Hubei will promote the establishment of centralized procurement of medical consortia, explore the procurement consortia led by large public hospitals for centralized procurement, and package and batch procurement through pharmaceutical trading enterprises, among which the most remarkable is the introduction of third-party group procurement organization (GPO) procurement There are also rumors that Chongqing, Zhongshan and other places are ready to move on the GPO issue Maybe it's only a matter of time before the GPO will spread more GPOs with Chinese characteristics have been explored in various places At the beginning of the 20th century, GPOs appeared in the United States The operation of GPOs is to save costs and reduce the pressure of rising costs by means of centralized purchasing through purchasing intermediaries GPO in China is relatively late It was not until 2016 that GPO practice began in Shanghai and Shenzhen In order to make the model successfully implemented in China, both of them have carried out more or less localized transformation of GPO For example, in the organizational unit, Shanghai Medical and health service center is responsible for promoting, and its background is a third-party non-profit organization under the guidance of the medical reform office Shenzhen is in charge of GPO project promotion As far as the scope of promotion is concerned, Shanghai has adopted the reform from five tertiary hospitals and six public hospitals affiliated to districts and counties, while Shenzhen has carried out the reform in an all-round way In terms of propulsion resistance, both have experienced some controversy For example, GPO in Shanghai has been exposed to be operating in a dark box, 29 enterprises have jointly signed up, and Shenzhen has also been accused of unfair operation Although it has gone through twists and turns, Shanghai is still steadily promoting GPO, while Shenzhen hospital procurement can choose both municipal GPO platform and provincial platform It is said that the former is mainly foreign investment and high price medicine, while the latter is mainly low price medicine GPOs or anything that should be considered for regulatory issues are multifaceted GPO not only emphasizes the market allocation, but also brings the worries of administrative intervention For example, GPO enables the purchaser to gain a dominant position in the market If the purchase and sales of drugs are controlled, the pharmaceutical enterprises will undoubtedly become a vulnerable group in the negotiation process If the price of drugs is lowered, how can the quality be guaranteed At the same time, if public hospitals require that drugs can only be purchased at a certain price or form, and then run on competitors, there may be market violations Whether it is the Shanghai mode, Shenzhen mode, Guangzhou or Foshan mode, to some extent, it is a way for the government to transfer part of its functions to a third-party platform However, after the government retired, how to supervise both drug companies and purchasers at the regulatory level will become a problem that has to be faced What I want to say later is that China's drug purchase mode presents a state of coexistence of multiple modes, such as provincial access, municipal standard entry, medical insurance embedding, GPO disruption, cross regional joint purchase, etc., coupled with two vote system and other bargaining and killing measures, how many moves can drug companies resist? Original title: GPO multi field extended drug purchase mode or change?